SYNAPTIC PHARMACEUTICALS
Synaptic Pharmaceutical Corporation develops human receptor-targeted drug design technology. The Company offers technology which is used to discover and clone the genes that code for human receptor subtypes that may be associated with specific disorders.
SYNAPTIC PHARMACEUTICALS
Industry:
Biotechnology Health Care Medical Pharmaceutical
Address:
Paramus, New Jersey, United States
Country:
United States
Status:
Active
Contact:
(201)261-1331
Similar Organizations
Addrenex Pharmaceuticals
Addrenex Pharmaceuticals develops drugs to regulate the adrenergic system.
Artenga
Artenga is a platform for drug delivery technology.
Axxia Pharmaceuticals
Axxia Pharmaceuticals provides implantable polymeric drug delivery technologies.
Integrative Enzymatics
Integrative Enzymatics has developed a proprietary method of designing pharmaceuticals.
Semafore Pharmaceuticals
Semafore Pharmaceuticals discovers and develops clinical-stage drugs.
Sustained Nano Systems
Sustained Nano Systems is a provider of nanoparticle-based drug delivery technology.
Talon Pharmaceuticals
Talon Pharmaceuticals is a multiphore drug design platform.
More informations about "Synaptic Pharmaceuticals"
Synaptic Pharmaceuticals Corp - Company Profile and News
Company profile page for Synaptic Pharmaceuticals Corp including stock price, company news, executives, board members, and contact informationSee details»
Synaptic Pharmaceuticals acquired by Lundbeck - Crunchbase
Nov 21, 2002 Synaptic Pharmaceuticals Synaptic Pharmaceuticals develops human receptor-targeted drug design technology. Acquiring Organization: Lundbeck Lundbeck is a …See details»
Synaptic Pharmaceutical Corporation - Products, Competitors, …
Synaptic Pharmaceutical Corporation was a Healthcare/Biotechnology company based in Paramus, New Jersey. Use the CB Insights Platform to explore Synaptic Pharmaceutical …See details»
Synaptic Pharmaceutical Corp. Information
Synaptic Pharmaceutical Corp., / Lundbeck Research USA is located at Paramus, NJ and is a leader in GPCR. Now that scientists have mapped the human genome, new opportunities exist …See details»
SYNAPTIC PHARMACEUTICAL CORP - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for SYNAPTIC PHARMACEUTICAL CORP of Paramus, NJ. Get the latest business insights from Dun & …See details»
Synaptic Pharmaceutical Corporation | www.inknowvation.com
Now doing business as Lundbeck Research USA, Inc the firm was previously called Neurogenetic Corporation, and then Synaptic Pharmaceutical Corporation is a biotechnology company …See details»
Synaptic Pharmaceuticals - Drug pipelines, Patents, Clinical trials ...
Explore Synaptic Pharmaceuticals with its drug pipeline, therapeutic area, technology platform, 2 literature, Disease Domain:Nervous System Diseases, Technology Platform:Small molecule …See details»
Synaptic Pharmaceuticals - Crunchbase
Synaptic Pharmaceuticals develops human receptor-targeted drug design technology.See details»
SYNAPTIC PHARMACEUTICALS Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for SYNAPTIC PHARMACEUTICALS of Peshawar, Khyber Pakhtunkhwa. Get the latest business insights …See details»
Synaptica 2025 Company Profile: Valuation, Funding & Investors
Synaptica General Information Description. Developer and provider of neuroscience-based biotechnology designed for drug discovery. The company develops novel drugs and diagnostic …See details»
Synaptic Pharmaceutical - Products, Competitors, Financials, …
Dec 13, 1995 Synaptic Pharmaceutical was founded in 1987. Where is Synaptic Pharmaceutical's headquarters? Synaptic Pharmaceutical's headquarters is located at 215 …See details»
SNAP-5114 - Drug Targets, Indications, Patents - Synapse
Mar 24, 2025 Originator Organization. Lundbeck Research USA, Inc. ... Synaptic Pharmaceuticals Lundbeck Research USA, Inc. Drug Highest Phase Pending Preclinical. First …See details»
SYNAPTIC PHARMACEUTICAL CORP Top 13F Holdings
Synaptic Pharmaceutical Corporation is a drug discovery company using its proprietary portfolio of G protein-coupled receptors (GPCRs) as the basis for developing new drugs for the treatment …See details»
Lundbeck buys Synaptic for $121m - Manufacturing Chemist
Danish pharmaceutical company H. Lundbeck has agreed to purchase US-based Synaptic Pharmaceutical Corporation for US$121m (Euro 119m), subject to approvals. Synaptic is a …See details»
Synaptics Pharmaceuticals Private Limited | Company Details
Jul 26, 2024 Synaptics Pharmaceuticals Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 September 2018 (Six years and four …See details»
Patents Assigned to Synaptic Pharmaceuticals Corporation
Jan 14, 2003 Assignee: Synaptic Pharmaceutical Corporation Inventors: John A. Salon, Thomas M. Laz, Raisa Nagorny, Amy E. Wilson Benzimidazoles and benzothiazoles and uses thereof. …See details»
Lunbeck acquires Synaptic in $122M deal - Pharmaceutical …
Mar 17, 2003 The bid to purchase Synaptic, which specializes in diseases of the central nervous system, was first announced late last year (Marketletter December 2, 2002). Lundbeck is …See details»
Lundbeck Acquiring Synaptic, CNS Pipeline For $121M In Cash
Nov 22, 2002 Synaptic Pharmaceutical Corp. signed a definitive merger agreement with like-minded central nervous system-focused H. Lundbeck A/S in a deal worth about $121 million. …See details»
DELTA: a method for brain-wide measurement of synaptic protein …
Mar 31, 2025 Here we describe a new method, DELTA, for mapping brain-wide changes in synaptic protein turnover with single-synapse resolution, based on Janelia Fluor dyes and …See details»
Objectives Methods - acumenpharm.com
Results Utility of human iPSC-derived neuronal model for evaluating synaptic binding of amyloid beta (Aβ) oligomers Elizabeth Johnson1, Hannah Maxwell2, Miriam Scarpa2, James Smith2, …See details»